Ignite Creation Date:
2024-05-06 @ 2:30 PM
Last Modification Date:
2024-10-26 @ 1:31 PM
Study NCT ID:
NCT04331626
Status:
UNKNOWN
Last Update Posted:
2020-04-02
First Post:
2020-03-31
Brief Title:
Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC
Sponsor:
Henan Cancer Hospital
Organization:
Henan Cancer Hospital